George Martin

George Kelly Martin is the founder of Brandon Point Industries Ltd. since 2014, holding the title of Director.
Current jobs include President & Chief Executive Officer at Elan Pharmaceuticals LLC since 2003, Chief Executive Officer at Malin Life Sciences Holdings Ltd., Chief Executive Officer at Radius Pharmaceuticals, Inc., Chairman at Serenus Biotherapeutics, Inc. since 2015, Executive Chairman at Wavebreak Therapeutics Ltd. since 2018, Executive Chairman at Transition Bio, Inc., and Vice Chairman at Ride Therapeutics, Inc. since 2020.
Former jobs include President, Chief Executive Officer & Director at Elan Corp.
Plc from 2013 to 2013, President, Chief Executive Officer & Director at Radius Health, Inc. from 2020 to 2022, Chief Executive Officer & Executive Director at Malin Corp.
Plc from 2015 to 2017, Chief Executive Officer at Elan Pharma Ltd., Director at Questcor Pharmaceuticals, Inc. from 2013 to 2014, Director at Viamet Pharmaceuticals, Inc., Non-Executive Director at NVN Liquidation, Inc. in 2020, Independent Director at Viamet Pharmaceuticals Corp., Non-Executive Director at Kymab Ltd., Director at Poseida Therapeutics, Inc., Non-Executive Director at Immunocore Holdings Plc, and Independent Director at TriSalus Life Sciences, Inc. from 2023 to 2025.
Education includes an undergraduate degree from Princeton University.